Elevai Labs News Today

NEWPORT BEACH, Calif., May 22, 2024 -- Elevai Labs Inc. , a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD will be presenting at the Los...

Certain Common Stock of Elevai Labs, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. These Common Stock will be under lockup for 181 days starting from 20-NOV-2023 to...

This article highlights upcoming events in the financial world, including quarterly earnings reports, IPOs, investor events, and market volatility updates.

Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 83,800 shares, a growth of 52.9% from the April 15th total of 54,800 shares. Based on an average daily volume of 370,600 shares, the short-interest ratio […]

Preclinical results of EL-22 from a 2022 study demonstrated physiological , physical , and functional improvements in the dystrophic features of mdx mice, a mouse model of Duchenne muscular dystrophy...

Elevai Labs established two subsidiaries: Elevai Biosciences, Inc., and Elevai Skincare, Inc. • Elevai Biosciences will focus on acquiring and developing…

Elevai Labs established two subsidiaries: Elevai Biosciences, Inc., and Elevai Skincare, Inc.Elevai Biosciences will focus on acquiring and developing biopharmaceutical technologies with initial focus...

Five international distribution agreements signed to dateCumulative contracted minimum purchase requirements of $4.9M in the first five yearsUp to five additional international distribution...

Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif.,...